Engineered sodium hyaluronate respirable dry powders for pulmonary drug delivery.

[1]  S. Kurajica,et al.  High Surface Area Ceria Nanoparticles via Hydrothermal Synthesis Experiment Design , 2016 .

[2]  Claus-Michael Lehr,et al.  Scope and relevance of a pulmonary biopharmaceutical classification system AAPS/FDA/USP Workshop March 16-17th, 2015 in Baltimore, MD , 2016 .

[3]  Ivan Rusyn,et al.  Assessment of biological responses of EpiAirway 3-D cell constructs versus A549 cells for determining toxicity of ambient air pollution , 2016, Inhalation toxicology.

[4]  R. Haag,et al.  Hyaluronic acid-shelled acid-activatable paclitaxel prodrug micelles effectively target and treat CD44-overexpressing human breast tumor xenografts in vivo. , 2016, Biomaterials.

[5]  V. Karunaratne,et al.  Effect of Lipid Composition on In Vitro Release and Skin Deposition of Curcumin Encapsulated Liposomes , 2016 .

[6]  H. Chan,et al.  Measuring Bipolar Charge and Mass Distributions of Powder Aerosols by a Novel Tool (BOLAR). , 2015, Molecular pharmaceutics.

[7]  J. Engblom,et al.  Hydration of hyaluronan: effects on structural and thermodynamic properties. , 2015, The journal of physical chemistry. B.

[8]  P. Colombo,et al.  Spray dried amikacin powder for inhalation in cystic fibrosis patients: a quality by design approach for product construction. , 2014, International journal of pharmaceutics.

[9]  P. Royall,et al.  Differences in physical chemistry and dissolution rate of solid particle aerosols from solution pressurised inhalers. , 2014, International journal of pharmaceutics.

[10]  P. Colombo,et al.  Pure insulin highly respirable powders for inhalation. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[11]  N. Quaranta,et al.  Intranasal sodium hyaluronate on the nasal cytology of patients with allergic and nonallergic rhinitis , 2013, International forum of allergy & rhinology.

[12]  F. Vergeldt,et al.  Influence of water content and drying on the physical structure of native hyaluronan. , 2013, Carbohydrate polymers.

[13]  G. De Rosa,et al.  Lipid-Based Nanovectors for Targeting of CD44-Overexpressing Tumor Cells , 2013, Journal of drug delivery.

[14]  D. Angelis,et al.  7% hypertonic saline and hyaluronic acid and in the treatment of infants mild-moderate bronchiolitis , 2011 .

[15]  R. Scherließ.  The MTT assay as tool to evaluate and compare excipient toxicity in vitro on respiratory epithelial cells. , 2011, International journal of pharmaceutics.

[16]  Nora Anne Urbanetz,et al.  The impact of electrostatic charge in pharmaceutical powders with specific focus on inhalation-powders , 2011 .

[17]  G. Turino,et al.  Therapeutic Effects of Hyaluronan on Smoke-induced Elastic Fiber Injury: Does Delayed Treatment Affect Efficacy? , 2011, Lung.

[18]  V. Orian-Rousseau.  CD44, a therapeutic target for metastasising tumours. , 2010, European journal of cancer.

[19]  F. Iskandar,et al.  Production of morphology-controllable porous hyaluronic acid particles using a spray-drying method. , 2009, Acta biomaterialia.

[20]  A. Ammit,et al.  Pulmonary Spray Dried Powders of Tobramycin Containing Sodium Stearate to Improve Aerosolization Efficiency , 2009, Pharmaceutical Research.

[21]  Seong-Mee Hwang,et al.  Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[22]  J. Cantor.  Potential therapeutic applications of hyaluronan in the lung , 2007, International journal of chronic obstructive pulmonary disease.

[23]  P. Pelosi,et al.  Bench-to-bedside review: The role of glycosaminoglycans in respiratory disease , 2006, Critical care.

[24]  L. Allegra,et al.  Aerosolised hyaluronic acid prevents exercise-induced bronchoconstriction, suggesting novel hypotheses on the correction of matrix defects in asthma. , 2006, Pulmonary pharmacology & therapeutics.

[25]  Ben Forbes,et al.  Hyaluronan: Pharmaceutical Characterization and Drug Delivery , 2005, Drug delivery.

[26]  G. Turino,et al.  Hyaluronan in respiratory injury and repair. , 2003, American journal of respiratory and critical care medicine.

[27]  M. Tammi,et al.  Hyaluronan and Homeostasis: A Balancing Act* , 2002, The Journal of Biological Chemistry.

[28]  S. Smedt,et al.  Hyaluronan: Preparation, Structure, Properties, and Applications , 1999 .

[29]  B. Gerdin,et al.  Dynamic role of hyaluronan (HYA) in connective tissue activation and inflammation , 1997, Journal of internal medicine.

[30]  Dian-zuo Wang.  Microanalysis of Flotation Reagents and Adsorption Measurement , 2016 .

[31]  Rebecca Lynn Johnson,et al.  Towards the bioequivalence of pressurised metered dose inhalers 1: design and characterisation of aerodynamically equivalent beclomethasone dipropionate inhalers with and without glycerol as a non-volatile excipient. , 2014, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.